D'ANDREA, GIACOMO
 Distribuzione geografica
Continente #
EU - Europa 436
NA - Nord America 310
AS - Asia 206
SA - Sud America 26
OC - Oceania 4
AF - Africa 3
Totale 985
Nazione #
US - Stati Uniti d'America 305
IT - Italia 222
SG - Singapore 147
DE - Germania 58
IE - Irlanda 46
SE - Svezia 23
BR - Brasile 21
FI - Finlandia 17
HK - Hong Kong 17
CN - Cina 16
RU - Federazione Russa 14
FR - Francia 13
NL - Olanda 13
TR - Turchia 10
GB - Regno Unito 8
IN - India 7
CA - Canada 5
ES - Italia 5
LT - Lituania 5
AT - Austria 4
AU - Australia 4
BE - Belgio 4
CL - Cile 2
CZ - Repubblica Ceca 2
KR - Corea 2
VN - Vietnam 2
AR - Argentina 1
CH - Svizzera 1
EC - Ecuador 1
EG - Egitto 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MA - Marocco 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
PY - Paraguay 1
TH - Thailandia 1
TN - Tunisia 1
Totale 985
Città #
Singapore 111
The Dalles 50
Dublin 44
Chandler 43
Munich 31
Ashburn 25
Milan 25
Rome 20
Santa Clara 20
Hong Kong 16
Silvi 15
Los Angeles 14
Pescara 12
Princeton 12
Chieti 10
Düsseldorf 10
Frankfurt am Main 10
Lappeenranta 10
Chicago 9
Teramo 8
Helsinki 7
Camerino 6
Nuremberg 6
Washington 6
Bologna 5
Castignano 5
Irsina 5
Altamura 4
Boardman 4
Brussels 4
Istanbul 4
San Potito Sannitico 4
Ankara 3
Lenno 3
Melbourne 3
Mumbai 3
Ottawa 3
Portsmouth 3
Reggio Calabria 3
Adana 2
Amsterdam 2
Augusta 2
Bhubaneswar 2
Boston 2
Brasília 2
Calamonte 2
Campi Bisenzio 2
Carmignano 2
Casalbordino 2
Dong Ket 2
Florence 2
Lauterbourg 2
Madrid 2
Magliano de' Marsi 2
Moscow 2
Naples 2
New York 2
Olomouc 2
Penne 2
Pioltello 2
Pune 2
Romola 2
Sant'Egidio alla Vibrata 2
Santiago 2
Scarsdale 2
Seattle 2
Seoul 2
Solagna 2
Syracuse 2
Tappahannock 2
Triuggio 2
Turin 2
Verona 2
Xiamen 2
Allumiere 1
Ancona 1
Avezzano 1
Badajoz 1
Bari 1
Beijing 1
Bofete 1
Bungarribee 1
Cairo 1
Caucete 1
Colombo 1
Cotiporã 1
Doctor Juan Eulogio Estigarribia 1
Erchie 1
Giulianova 1
Krasnodar 1
Lahore 1
Leawood 1
Lecce 1
London 1
Londrina 1
Luziânia 1
Maastricht 1
Meyzieu 1
Mirassol 1
Montreuil 1
Totale 672
Nome #
Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING) 102
Hypomanic/manic switch after transcranial magnetic stimulation in mood disorders: A systematic review and meta-analysis 77
Non-invasive brain stimulation targets and approaches to modulate gambling-related decisions: A systematic review 62
Hopelessness, dissociative symptoms, and suicide risk in major depressive disorder: Clinical and biological correlates 56
Impact of sleep disorders and disease duration on neurotrophins levels in cocaine use disorder 52
Intranasal esketamine as tool for rapid cycling bipolar disorder: A case report of successful mood stabilization 50
From a cycle to a period: the potential role of BDNF as plasticity and phase-specific biomarker in cocaine use disorder 50
Enhanced peripheral levels of BDNF and proBDNF: elucidating neurotrophin dynamics in cocaine use disorder 47
Combining Dopamine Agonists With Accelerated Repetitive Transcranial Magnetic Stimulation: A Case of Successful Treatment of Resistant Depression 45
Addiction biotypes: a paradigm shift for future treatment strategies? 44
Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature 43
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study 35
Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group 35
Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine 33
Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study) 33
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data 31
Overcoming treatment-resistant depression with machine-learning based tools: a study protocol combining EEG and clinical data to personalize glutamatergic and brain stimulation interventions (SelecTool Project) 28
Efficacy of Noninvasive Brain Stimulation on Borderline Personality Disorder Core Symptoms: A Systematic Review 27
The transition time to gambling disorder: The roles that age, gambling preference and personality traits play 26
Language proficiency and mental disorders among migrants: A systematic review 25
Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: an observational, real-world study 23
null 22
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression 21
Investigating the Role of Maintenance TMS Protocols for Major Depression: Systematic Review and Future Perspectives for Personalized Interventions 16
Corrigendum to “Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine” [Brain Stimul 16 (2023)] 12
Efficacy of Psychosocial and Psychological Interventions in Addition to Drug Therapy to Improve Global Functioning of Inpatients with Schizophrenia Spectrum and Mood Disorders: A Real-World Observational Study 12
A narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophrenia 11
Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation 11
Effect of anticholinergic burden on brain activity during Working Memory and real-world functioning in patients with schizophrenia 10
Rethinking ketamine and esketamine action: Are they antidepressants with mood-stabilizing properties? 8
New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances 7
Exploring the potential of a bridge therapy: Synergistic approach integrating intravenous ketamine and intranasal esketamine for treatment‐resistant depression 6
Esketamine Treatment Trajectory of Patients with Treatment-Resistant Depression in the Mid and Long-Term Run: Data from REAL-ESK Study Group 5
Dopaminergic dysfunction in the left putamen of patients with major depressive disorder 5
An open-label pilot trial of a five-day, accelerated rTMS protocol in bipolar II depression 5
Linking Striatal Dopaminergic Asymmetry with Personality Traits: Insights from Gambling Disorder 4
Exploring vortioxetine combination with intranasal esketamine: A feasible alternative to SSRI/SNRI? - Insights from the REAL-ESK study 2
Totale 1.081
Categoria #
all - tutte 8.045
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.045


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121 0 0 0 0 0 0 6 2 4 0 7 2
2021/202223 1 0 0 0 1 0 0 3 4 2 2 10
2022/2023150 7 18 10 5 18 25 8 14 32 4 2 7
2023/2024311 10 19 35 16 37 44 37 29 18 16 15 35
2024/2025576 50 107 68 49 41 23 53 29 48 67 41 0
Totale 1.081